Ilepatril

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameIlepatril
Drug Alias Name艾尔帕曲IlepatrilumIlepatriloMDL-107688AVE-7688
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsNeprilysin inhibitors
TargetsAngiotensin-converting enzymeNeprilysin
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[21] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A